Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment for Adolescents With Depression Study (TADS)
NCT00006286Phase 3Completed
- Sponsor
- National Institute of Mental Health
- Start
- Sep 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluoxetine in major depressive disorder (MDD), sponsored by National Institute of Mental Health. Started Sep 1998; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00006286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006286.